advanceCOR GmbH
🇩🇪Germany
- Country
- 🇩🇪Germany
- Ownership
- Holding
- Established
- 2012-01-01
- Employees
- 1
- Market Cap
- -
- Website
- http://www.advancecor.com
Clinical Trials
4
Active:2
Completed:2
Trial Phases
2 Phases
Phase 1:3
Phase 2:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (4 trials with phase data)• Click on a phase to view related trials
Phase 1
3 (75.0%)Phase 2
1 (25.0%)Revacept in Symptomatic Carotid Stenosis
Phase 2
Completed
- Conditions
- TIAStrokeAmaurosis FugaxCarotid StenosisAtherosclerosisTransient-ischaemic Attack
- Interventions
- Drug: Placebo
- First Posted Date
- 2012-07-20
- Last Posted Date
- 2021-01-28
- Lead Sponsor
- AdvanceCor GmbH
- Target Recruit Count
- 158
- Registration Number
- NCT01645306
- Locations
- 🇩🇪
Site 01: Department of Neurology, TU Munich, Munich, Bavaria, Germany
🇩🇪Site 08: Universitätsklinikum Essen, Klinik für Neurologie, Essen, Germany
🇩🇪Site 11: Universitätsklinikum Hamburg Eppendorf, Hamburg, Germany
Safety, Pharmacokinetic and -Dynamic Study of PR-15, an Inhibitor of Platelet Adhesion
Phase 1
Completed
- Conditions
- ThrombosisAcute Coronary SyndromeMyocardial InfarctionStroke
- First Posted Date
- 2010-01-06
- Last Posted Date
- 2012-10-19
- Lead Sponsor
- AdvanceCor GmbH
- Target Recruit Count
- 30
- Registration Number
- NCT01042964
- Locations
- 🇩🇪
ABX-CRO/Medifacts GmbH, Goerlitz, Saxony, Germany
News
No news found